A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines

European Journal of Marketing

Volumn 39, Issue 9-10, 2005, Pages 1151-1165

  Hoek, Janet ^a   Maubach, Ninya ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Advertising; Direct marketing; Marketing information; Regulation; Stakeholder analysis

Indexed keywords

EID: 25844493233     PISSN: 03090566     EISSN: None     Source Type: Journal    
DOI: 10.1108/03090560510610770     Document Type: Article

References (41)

1. Abratt, R. and Sacks, D. (1988), "The marketing challenge: towards being profitable and socially responsible", Journal of Business Ethics, Vol. 7, pp. 497-507.
2. Atkinson, A., Waterhouse, J. and Wells, R. (1997), "A stakeholder approach to strategic performance measurement", Sloan Management Review, Vol. 38 No. 3, pp. 25-37.
3. Carrigan, M. (1995), "POSIT-ive and negative aspects of the societal marketing concept: stakeholder conflicts of the tobacco industry", Journal of Marketing Management, Vol. 11, pp. 469-85.
4. DeBussy, N., Ewing, M. and Pitt, L. (2003), "Stakeholder theory and internal marketing communications: a framework for analysing the influence of new media", Journal of Marketing Communications, Vol. 9 No. 3, pp. 147-61.
5. Donaldson, T. and Preston, L. (1995), "The stakeholder theory of the corporation: concepts, evidence, implications", Academy of Management Review, Vol. 20 No. 1, pp. 65-91.
6. Elms, H., Berman, S. and Wicks, A. (2002), "Ethics and incentives: an evaluation and development of stakeholder theory in the health-care industry", Business Ethics Quarterly, Vol. 12 No. 4, pp. 413-32.
7. Freeman, R. (1984), Strategic Management: A Stakeholder Approach, Pitman, Boston, MA.
8. Freeman, R. (1994), "The politics of stakeholder theory: some future directions", Business Ethics Quarterly, Vol. 4 No. 4, pp. 409-21.
9. Friedman, A. and Miles, S. (2002), "Developing stakeholder theory", Journal of Management Studies, Vol. 39 No. 1, pp. 1-21.
10. Friedman, M. (1970), "The social responsibility of business is to increase its profits", New York Times Magazine, Vol. 122, September 13, pp. 32-3.
11. Gibson, K. (2000), "The moral basis of stakeholder theory", Journal of Business Ethics, Vol. 26, pp. 245-57.
12. Greenley, G. and Foxall, G. (1997), "Multiple stakeholder orientation in UK companies and the implications for company performance", Journal of Management Studies, Vol. 34 No. 2, pp. 259-84.
13. Gregory, R. and Keeney, R. (1994), "Creating policy alternatives using stakeholder values", Management Science, Vol. 40 No. 8, pp. 1035-48.
14. Hastak, M., Mazis, M. and Morris, L. (2001), "The role of consumer surveys in public policy decision making", Journal of Public Policy and Marketing, Vol. 20 No. 2, pp. 170-85.
15. Hoek, J., Gendall, P. and Calfee, J. (2004), "Direct to consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses", International Journal of Advertising, Vol. 23 No. 2, pp. 197-227.
16. Jawahar, I. and McLaughlin, G. (2001), "Toward a descriptive stakeholder theory: an organisation life cycle approach", Academy of Management Review, Vol. 26 No. 3, pp. 317-414.
17. Jones, T. and Wicks, A. (1999), "Convergent stakeholder theory", Academy of Management Review, Vol. 24 No. 2, pp. 206-21.
18. Kaler, J. (2003), "Differentiating stakeholder theories", Journal of Business Ethics, Vol. 46 No. 1, pp. 71-83.
19. King, A. (2003), "Mid-winter dialogue, Christchurch Medical School", speech delivered 7 August, available at: www.beehive.govt.nz/ ViewDocument.cfm?DocumentID=17505.
20. Lexchin, J. and Mintzes, B. (2002), "Direct-to-consumer advertising of prescription drugs: the evidence says no", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 194-202.
21. Maignan, I. and Ferrell, O.C. (2004), "Corporate social responsibility and marketing: an integrative framework", Journal of the Academy of Marketing Science, Vol. 32 No. 1, pp. 3-19.
22. Mellahi, K. and Wood, G. (2003), "The role and potential of stakeholders in hollow participation: conventional stakeholder theory and institutionalist alternatives", Business and Society Review, Vol. 108 No. 2, pp. 183-202.
23. Miller, R. and Lewis, W. (1991), "A stakeholder approach to marketing management using the value exchange model", European Journal of Marketing, Vol. 25 No. 8, pp. 55-68.
24. Mitchell, R., Agle, B. and Wood, D. (1997), "Toward a theory of stakeholder identification and salience: defining the principle of who and what really count", Academy of Management Review, Vol. 22 No. 4, pp. 853-86.
25. Page, C. (2002), "The development of organisation stakeholder salience in public health", Journal of Public Health Management Practice, Vol. 8 No. 5, pp. 76-84.
26. Petkus, E. and Woodruff, R. (1992), "A model of socially responsible decision-making processes in marketing: linking decision makers and stakeholders", Marketing Theory and Application, Vol. 3, pp. 154-61.
27. PHARMAC (2000), submission for Ministry of Health Review of Direct to Consumer Advertising, PHARMAC, Wellington, November.
28. Phillips, R., Freeman, R.E. and Wicks, A. (2003), "What stakeholder theory is not", Business Ethics Quarterly, Vol. 13 No. 4, pp. 479-502.
29. Polonsky, M.J. (1995), "A stakeholder theory approach to designing environmental marketing strategy", Journal of Business & Industrial Marketing, Vol. 10 No. 3, pp. 29-46.
30. Polonsky, M.J., Carlson, L. and Fry, M.L. (2003), "The harm chain: a public policy development and stakeholder perspective", Marketing Theory, Vol. 3 No. 3, pp. 345-64.
31. Polonsky, M.J., Suchard, H. and Scott, D. (1999), "The incorporation of an interactive external environment: an extended model of marketing relationships", Journal of Strategic Marketing, Vol. 7 No. 1, pp. 41-55.
32. Potts, A., Gavey, N., Grace, V. and Vares, T. (2003), "The downside of Viagra: women's experiences and perspectives", Sociology of Health & Illness, Vol. 25 No. 7, pp. 697-719.
33. Smith, H.J. (2003), "The shareholders vs stakeholders debate", MIT Sloan Management Review, Summer, pp. 85-90.
34. Toop, L., Richards, D., Dowell, T., Tilyard, M., Fraser, T. and Arroll, B. (2003), "Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit?", available at: www.chmeds.ac.nz/report. pdf.
35. Waddock, S., Bodwell, C. and Graves, S. (2002), "Responsibility: the new business imperative", Academy of Management Executive, Vol. 16 No. 2, pp. 132-48.
36. Werhane, P. (2000), "Business ethics, stakeholder theory and the ethics of healthcare organisations", Cambridge Quarterly of Health-care Ethics, Vol. 9, pp. 169-81.
37. Werhane, P. and Freeman, R. (1999), "Business ethics: the state-of-the-art", International Journal of Management Review, Vol. 1 No. 1, pp. 1-16.
38. Whysall, P. (2000), "Addressing ethical issues in retailing: a stakeholder perspective", International Review of Retail, Distribution and Consumer Research, Vol. 10 No. 3, pp. 305-18.
39. Wiggs, G. (2003), "The New Zealand experience with DTC", paper presented at the American Enterprise Institute Seminar, Washington, DC, May 29.
40. Brønn, P. and Brønn, G. (2003), "A reflective stakeholder approach: co-orientation as a basis for communication and learning", Journal of Communication Management, Vol. 7 No. 4, pp. 291-303.
41. Calfee, J. (2002), "Public policy issues in direct-to-consumer advertising of prescription drugs", Journal of Public Policy & Marketing, Vol. 21 No. 2, pp. 174-93.